TRAXFirst Tracks Biotherapeutics Inc. Ordinary Shares
43.11USD-5.25%Mkt Cap: 1.54B $P/E: —3d ago
First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States. Its products includes ANB033, a …